Yüklüyor......
Immunotherapy: Who is Eligible?
Recurrent and/or metastatic head and neck cancer portends a poor prognosis with traditional treatments, but current immunotherapy with immune checkpoint inhibitors has the potential to improve these clinical outcomes. This review focuses on the major breakthroughs that have led to our current unders...
Kaydedildi:
| Yayımlandı: | Otolaryngol Clin North Am |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282181/ https://ncbi.nlm.nih.gov/pubmed/28755708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.otc.2017.04.006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|